Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study of Remifentanil for Laryngeal Mask Airway Insertion During Induction Using Remimazolam

NCT06289829 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06289829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06289829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study of Remifentanil for Laryngeal Mask Airway Insertion During Induction Using Remimazolam
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Completed
Start date
April 4, 2024
Completion date
March 12, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult, laryngeal masks, remimazolam, remifentanil